A Case Study of Soeumin with Peripheral T-cell Lymphoma who Showed Symptomatic Improvement including Fever, Myalgia, Performance Status, and Headache after Treated with Osuyubujaijung-tang and Geopoong-san (吳茱萸附子理中湯 및 祛風散으로 발열, 통증, 전신활동도, 두통 호전을 보인 소음인 말초성 T세포 림프종 환자 1례)

최성헌; 송안나; 안지혜; 김은희; 박소정; 김경석; Lee Sookyung (이수경)

doi:10.7730/JSCM.2012.24.4.100

A Case Study of Soeumin with Peripheral T-cell Lymphoma who Showed Symptomatic Improvement including Fever, Myalgia, Performance Status, and Headache after Treated with Osuyubujaijung-tang and Geopoong-san

Journal of Sasang Constitution and Immune Medicine
Abbr : JSCIM
2012, 24(4), pp.100~108
DOI : 10.7730/JSCM.2012.24.4.100
Publisher : The Society of Sasang Constitution and Immune Medicine
Research Area : Medicine and Pharmacy > Korean Medicine

최성헌 ¹, 송안나 ¹, 안지혜 ¹, 김은희 ¹, 박소정 ¹, 김경석 ¹, Lee Sookyung ¹

¹경희대학교

Accredited

ABSTRACT

Objectives The aim of this study was to report the improvement of fever, myalgia, performance status, and headache after treatment with Osuyubujaijung-tang and Geopoong-san in a Soeumin with Peripheral T-cell lymphoma. Methods We retrospectively reviewed the medical records, medical laboratory and image scans of 80-year-old male patient diagnosed as peripheral T-cell lymphoma. He couldn't conduct any conventional chemotherapy due to poor performance status, ECOG 4. Results The symptoms of myalgia, poor performance status, and neck pain improved, and fever was reduced with Osuyubujaijung-tang. Headache was subsided with Geopoong-san. Conclusions A patient with peripheral T-cell lymphoma suffering from fever, myalgia, poor performance status, neck pain and headache showed the improvement of symptoms with treatment of Osuyubujaijung-tang and Geopoong-san. After 4 months treatment, the patient could conduct self care, physical activity and social affairs.

KEYWORDS

peripheral T-cell lymphoma(PTCL), fever, pain, performance status, Osuyubujaijung-tang, Geopoong-san

Journal Copyright Policy

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Citation status

* References for papers published after 2025 are currently being built.

[journal] 조홍성 / 2010 / A case of peripheral T-cell lymphoma presenting with a necrotizing gingival ulcer / 대한내과학회지 / 대한내과학회 78(6) : 766~770

[journal] Oken MM / 1982 / Toxicity and response criteria of the Eastern Cooperative Oncology Group / Am J Clin Oncol 5(6) : 649~55

[journal] Joo Ryung Huh / 2012 / Epidemiologic overview of malignant lymphoma / Blood Research / 대한혈액학회 47(2) : 92~104

[journal] Harris NL / 1999 / World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues : report of the Clinical Advisory Committee meeting-Airlie House, Virginia, Noember 1997 / J Clin Oncol 17 : 3835~3849

[journal] Siegel R / 2012 / Cancer statistics, 2012 / CA Cancer J Clin 62 : 10~29

[journal] Vose J / 2008 / International peripheral T-cell and natural killer/T-cell lymphoma study : pathology findings and clinical outocmes / J Clin Oncol 26 : 4124~4130

[journal] Cadranel J / 2002 / Primary pulmonary lymphoma / Eur Respir J 20 : 750~762

[book] Dan L. Longo / 2008 / Malignancies of Lymphoid Cells, In Harrison's Principles of Internal Medicine, 17th ed / McGraw-Hill : 687~700

[journal] Savage KJ / 2008 / ALK-ana-plastic large-cell lymphoma is clinically and im-munophenotypically different from both ALK+ALCL and peripheral T-cell lymphoma, not other-wise specified : report from the International Pe-ripheral T-Cell Lymphoma Project / Blood 111(12) : 5496~5504

[journal] Francine M. Foss / 2011 / Peripheral T-cell lymphoma / Blood 117 : 6756~6767

[journal] Abouyabis AN / 2007 / Response and survival rates in patients with periph-eral T-cell lymphoma treated with anthracycline-based regimens: a comprehensive meta-analysis [abstract] / Blood 110(11)

[book] Cho HS / 2011 / Principles and Prescriptionology of Sasang Constitutional medicine / Jipmoondang : 276~280

[journal] Shin DY / 2004 / A Clinical Study on One Patient Diagnosed as "Soeumin Eumsungkyukyang" as well as Suffering from Atrial Fibrillation / J Sasang Constitut Med 16(3) : 114~117

[journal] 최원철 / 2006 / Study on Antiangiogenic and Antitumor Activities of Processed Rhus verniciflua Stokes extract / 동의생리병리학회지 / 대한동의병리학회 20(4) : 825~829

[journal] 김황필 / 200607 / Inhibition of cell cycle progression via p27(Kip1) upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua Stokes in AGS gastric cancer cells / INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE / PROFESSOR D A SPANDIDOS 18(1) : 201~208

[journal] Lee SJ / 2005 / 36 kDa glycoprotein isolated from Rhus verniciflua Stokes inhibits G/GO-induced mitochondrial apoptotic signal pathways in BNL CL.2 cells / Basic Clin Pharmacol Toxicol 97(6) : 399~405

[journal] 이성옥 / 200606 / Anti-platelet effects of bioactive compounds isolated from the bark of Rhus verniciflua Stokes / JOURNAL OF ETHNOPHARMACOLOGY / ELSEVIER IRELAND LTD 106(1) : 62~69

[journal] 임계택 / 200602 / Hypolipidemic and antioxidative effects of the plant glycoprotein (36 kDa) from Rhus verniciflua stokes fruit in Triton WR-1339-induced hyperlipidemic mice / BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY / JAPAN SOC BIOSCI BIOTECHN AGROCHEM 70(2) : 447~456

[journal] Choi WC / 2012 / Rhus verniciflua Stokes against Advanced Cancer: A Perspective from the Korean Integrative Cancer Center / J Biomed Biotechnol : 1~7

[journal] Heo DS / 1998 / Peripheral T-cell lymphomas Presenting as Fever of Unknown Origin / J Korean Cancer Assoc 30(2) : 329~337

KJCKorea
Journal Central

Journal of Sasang Constitution and Immune Medicine 2025 KCI Impact Factor : 0.95